Patent assignee · FR · COMPANY

STALLERGENES

🏢 View company profile →
13Patents
12Active
13Granted
47Portfolio score

Filing activity: Nov 25, 2002 → Jan 26, 2017 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9480748B2 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance Human Necessities 1 Active
US10101341B2 Biomarkers of immunotherapy efficacy Physics 1 Active
US11015221B2 Markers of immune response Chemistry; Metallurgy 0 Active
US11028441B2 IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy Physics 0 Active
US7285650B2 Cloning and sequencing of the allergen Dac g5 of Dactylis glomerata pollen, its preparation and its use Human Necessities 0 Expired
US10610586B2 Compositions for antigen-specific induction of tolerance Human Necessities 0 Active
US9795644B2 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids Human Necessities 0 Active
US10190166B2 Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy Chemistry; Metallurgy 0 Active
US11027010B2 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids Human Necessities 0 Active
US10884002B2 Sialylated fetuin-A as a marker of immunotherapy efficacy Physics 0 Active
US9868770B2 Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes Chemistry; Metallurgy 0 Active
US9555102B2 Compositions for antigen-specific induction of tolerance Human Necessities 0 Active
US9822185B2 Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.